Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2021-10-08 00:00:00 ET · period of report 2021-10-06 · accession 0000899243-21-039697 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-10-08 | 2021-10-06 | BEAM | Evans John M. | CEO, Dir | S - Sale+OE | $83.80 | -27.7K | 1.04M | -3% | -$2.32M |
| DMI | 2021-10-08 | 2021-10-06 | BEAM | Evans John M. | CEO, Dir | S - Sale+OE | $83.80 | -20.0K | 183.0K | -10% | -$1.68M |
| D | 2021-10-08 | 2021-10-06 | BEAM | Evans John M. | CEO, Dir | M - OptEx | $1.03 | +27.7K | 1.06M | +3% | +$28.5K |
| D | 2021-10-08 | 2021-10-06 | BEAM | Evans John M. | CEO, Dir | M - OptEx | $0.00 | -27.7K | 331.6K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-06 | S | D | 701 | $85.19 | 1,033,525 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $85.03 to $85.32, inclusive. |
| 2 | Common | Common Stock | 2021-10-06 | S | D | 2,171 | $82.71 | 200,829 | I | — | — | (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $82.465 to $82.97, inclusive. |
| 3 | Common | Common Stock | 2021-10-06 | S | D | 9,863 | $83.49 | 190,966 | I | — | — | (F8) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $83.08 to $83.98, inclusive. |
| 4 | Common | Common Stock | 2021-10-06 | S | D | 7,566 | $84.45 | 183,400 | I | — | — | (F9) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $84.07 to $84.98, inclusive. |
| 5 | Common | Common Stock | 2021-10-06 | S | D | 10,444 | $84.45 | 1,034,226 | D By John M. Evans, III 2018 Irrevocable Trust | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $84.005 to $84.98, inclusive. |
| 6 | Common | Common Stock | 2021-10-06 | M | A | 27,700 | $1.03 | 1,061,225 | D By John M. Evans, III 2018 Irrevocable Trust | — | — | |
| 7 | Common | Common Stock | 2021-10-06 | S | D | 3,149 | $82.72 | 1,058,076 | D By John M. Evans, III 2018 Irrevocable Trust | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $82.465 to $82.995, inclusive. |
| 8 | Common | Common Stock | 2021-10-06 | S | D | 13,406 | $83.47 | 1,044,670 | D By John M. Evans, III 2018 Irrevocable Trust | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $83.04 to $83.98, inclusive. |
| 9 | Common | Common Stock | 2021-10-06 | S | D | 400 | $85.24 | 183,000 | I | — | — | (F10) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $85.07 to $85.31, inclusive. |
| 10 | Derivative | Stock Option (Right to Buy) | 2021-10-06 | M | D | 27,700 | $0.00 | 331,645 | D | $1.03 · — to 2028-07-13 | 27,700 Common Stock | (F11) The option vests as to 25% on the first anniversary of the of the vesting commencement date, January 8, 2018, and at a rate of 2.78% each month thereafter until the option is fully vested. |